The management of chronic breathlessness in patients with advanced and terminal illness

BMJ (Online)

Volumn 349, Issue , 2015, Pages

  Ekström, Magnus P ^a,d   Abernethy, Amy P ^b   Currow, David C ^c  

^a LUND UNIVERSITY   (Sweden)

^b FLINDERS UNIVERSITY   (Australia)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d BLEKINGE HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; FUROSEMIDE; MORPHINE; OPIATE DERIVATIVE; OXYGEN; PLACEBO; SODIUM CHLORIDE; NARCOTIC ANALGESIC AGENT;

ANXIETY DISORDER; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONSTIPATION; DISEASE DURATION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DYSPNEA; EVIDENCE BASED MEDICINE; HEART FAILURE; HUMAN; KIDNEY DISEASE; LABORATORY TEST; LOW DRUG DOSE; MALIGNANT NEOPLASTIC DISEASE; MEDICAL HISTORY; NAUSEA; NONINVASIVE VENTILATION; NOTE; OXYGEN THERAPY; PAIN; PALLIATIVE THERAPY; PATIENT CARE; PHYSICAL ACTIVITY; PHYSICAL EXAMINATION; PREVALENCE; PSYCHOSOCIAL CARE; PULMONARY REHABILITATION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATION DEPRESSION; RESPIRATORY FAILURE; RISK BENEFIT ANALYSIS; SEDENTARY LIFESTYLE; SELF REPORT; SUSTAINED DRUG RELEASE; TERMINAL DISEASE; TREATMENT RESPONSE; WALKING AID; PATHOPHYSIOLOGY; PROCEDURES; RESPIRATION CONTROL; TERMINAL CARE; TERMINALLY ILL PATIENT;

AIRWAY MANAGEMENT; ANALGESICS, OPIOID; DYSPNEA; HUMANS; PALLIATIVE CARE; TERMINAL CARE; TERMINALLY ILL;

EID: 84920812270     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.g7617     Document Type: Note

References (29)

1. Currow DC, Plummer JL, Crockett A, Abernethy AP. A community population survey of prevalence and severity of dyspnea in adults. J Pain Symptom Manage 2009;38:533-45.
2. Pratter MR, Abouzgheib W, Akers S, et al. An algorithmic approach to chronic dyspnea. Respir Med 2011;105:1014-21.
3. Moens K, Higginson IJ, Harding R. Are there differences in the prevalence of palliative care-related problems in people living with advanced cancer and eight non-cancer conditions? a systematic review. J Pain Symptom Manage 2014;48:660-77.
4. Currow DC, Smith J, Davidson PM, et al. Do the trajectories of dyspnea differ in prevalence and intensity by diagnosis at the end of life? A consecutive cohort study. J Pain Sympt Manage 2010;39:680-90.
5. Nishimura K, Izumi T, Tsukino M, et al. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 2002;121:1434-40.
6. Johnson MJ, Bland JM, Oxberry SG, et al. Clinically important differences in the intensity of chronic refractory Breathlessness. J Pain Symptom Manage 2013;46:957-63.
7. Campbell ML, Templin T, Walch J. A respiratory distress observation scale for patients unable to self-report dyspnea. J Palliat Med 2010;13:285-90.
8. Pedersen F, Mehlsen J, Raymond I, et al. Evaluation of dyspnoea in a sample of elderly subjects recruited from general practice. Int J Clin Pract 2007;61:1481-91.
9. th ed. Saunders-Elsevier, 2010.
10. Abernethy AP, Currow DC, Frith P, Fazekas BS, McHugh A, Bui C. Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. BMJ 2003;327:523-8.
11. Bolton CE, Bevan-Smith EF, Blakey JD, Crowe P, Elkin SL, Garrod R, et al. British Thoracic Society guideline on pulmonary rehabilitation in adults. Thorax 2013;68:ii1-30.
12. Jennings AL, Davies AN, Higgins JP, Gibbs JS, Broadley KE. A systematic review of the use of opioids in the management of dyspnoea. Thorax 2002;57:939-44.
13. Abernethy AP, McDonald CF, Frith PA, et al. Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial (NCT 00327873). Lancet 2010;376:784-93.
14. Campbell ML, Yarandi H, Dove-Medows E. Oxygen is nonbeneficial for most patients who are near death. J Pain Symptom Manage 2013;45:517-23.
15. Simon ST, Higginson IJ, Booth S, et al. Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults. Cochrane Database Syst Rev 2010;1:CD007354.
16. Pratter MR, Curley FJ, Dubois J, et al. Cause and evaluation of chronic dyspnea in a pulmonary disease clinic. Arch Intern Med 1989;149:2277-82.
17. Lecasse Y, Goldstein R, Lasserson TJ, Martin S. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006;CD003793.
18. Carone M, Patessio A, Ambrosino N, et al. Efficacy of pulmonary rehabilitation in chronic respiratory failure (CRF) due to chronic obstructive pulmonary disease (COPD): Tthe Maugeri Study. Respir Med 2007;101:2447-53.
19. Higginson IJ, Bausewein C, Reilly CC, et al. An integrated palliative and respiratory care service for patients with advanced disease and refractory breathlessness: a randomised controlled trial. Lancet Resp Med 2014, published online 29 Oct.
20. Nava S, Ferrer M, Esquinas A, et al. Palliative use of non-invasive ventilation in end-of-life patients with solid tumours: a randomised feasibility trial. Lancet Oncol 2013;14:219-27.
21. Struik FM, Lacasse Y, Goldstein R, et al. Nocturnal non-invasive positive pressure ventilation for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2013;6:CD002878.
22. Bausewein C, Booth S, Gysels M, et al. Effectiveness of a hand-held fan for breathlessness: a randomised phase II trial. BMC Palliat Care 2010;9:22.
23. Mahler DA, Gifford AH, Waterman LA, et al. Effect of increased blood levels of beta-endorphin on perception of breathlessness. Chest 2013;143:1378-85.
24. Johnson MJ, Bland JM, Oxberry SG, et al. Opioids for chronic refractory breathlessness: patient predictors of beneficial response. Eur Respir J 2013;42:758-66.
25. Oxberry SG, Torgerson DJ, Bland JM, et al. Short-term opioids for breathlessness in stable chronic heart failure: a randomized controlled trial. Eur J Heart Fail 2011;13:1006-12.
26. Johnson MJ, McDonagh TA, Harkness A, et al. Morphine for the relief of breathlessness in patients with chronic heart failure-a pilot study. Eur J Heart Fail 2002;4:753-6.
27. Currow DC, McDonald C, Oaten S, et al. Once-daily opioids for chronic dyspnea: a dose increment and pharmacovigilance study. J Pain Symptom Manage 2011;42:388-99.
28. Ekstrom MP, Bornefalk-Hermansson A, Abernethy AP, et al. Safety of benzodiazepines and opioids in very severe respiratory disease: national prospective study. BMJ 2014;348:g445.
29. Uronis H, McCrory DC, Samsa G, et al. Symptomatic oxygen for non-hypoxaemic chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2011;6:CD006429.